1. 1) Chambers J. D., Thorat T., Wilkinson C. L., Neumann P. J., Health Aff. (Millwood), 36, 1408–1415 (2017).
2. 2) Yver A., Ann. Oncol., 27, 1165–1170 (2016).
3. 3) “Novel Drug Approvals for 2022.”: ‹Novel Drug Approvals for 2022|FDA›, cited 9 February, 2023.
4. 4) China: National Medical Products Administration. 2017. “China drug review annual report.”: ‹https://www.nmpa.gov.cn/›, cited 9 June, 2021.
5. 5) China: National Medical Products Administration. 2018. “China drug review annual report.”: ‹https://www.nmpa.gov.cn/›, cited 9 June, 2021.